| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
22,842 |
20,910 |
$3.77M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
22,500 |
20,094 |
$3.36M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
23,153 |
19,996 |
$3.00M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
18,787 |
16,053 |
$1.23M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
18,319 |
15,872 |
$992K |
| 71046 |
Radiologic examination, chest; 2 views |
7,452 |
6,606 |
$843K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
4,935 |
4,479 |
$394K |
| 71045 |
Radiologic examination, chest; single view |
2,093 |
1,829 |
$307K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
8,212 |
6,909 |
$292K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
5,982 |
5,372 |
$258K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
748 |
624 |
$249K |
| 90837 |
Psychotherapy, 53 minutes with patient |
1,344 |
746 |
$154K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
27,266 |
23,031 |
$129K |
| 36415 |
Collection of venous blood by venipuncture |
29,561 |
25,059 |
$116K |
| 87503 |
|
4,316 |
3,937 |
$102K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,638 |
2,447 |
$94K |
| 81025 |
|
14,958 |
13,267 |
$79K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
16,789 |
14,419 |
$74K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,405 |
1,130 |
$62K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
1,060 |
183 |
$58K |
| 85027 |
|
15,340 |
13,316 |
$56K |
| 84484 |
|
8,390 |
4,636 |
$45K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
514 |
462 |
$40K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
6,465 |
5,299 |
$32K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
452 |
373 |
$29K |
| 70450 |
Computed tomography, head or brain; without contrast material |
213 |
169 |
$21K |
| 80076 |
|
4,086 |
3,517 |
$21K |
| 81001 |
|
11,760 |
10,431 |
$20K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
305 |
141 |
$20K |
| 80053 |
Comprehensive metabolic panel |
3,471 |
3,072 |
$19K |
| 59025 |
Fetal non-stress test |
51 |
44 |
$17K |
| 83690 |
|
4,942 |
4,250 |
$17K |
| 81003 |
|
8,345 |
7,140 |
$12K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
215 |
198 |
$9K |
| 64493 |
|
15 |
12 |
$6K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
126 |
36 |
$6K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,424 |
1,252 |
$5K |
| 80348 |
|
64 |
38 |
$5K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
246 |
215 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
101 |
80 |
$4K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
187 |
149 |
$4K |
| 90834 |
Psychotherapy, 45 minutes with patient |
32 |
26 |
$4K |
| 80320 |
|
32 |
29 |
$2K |
| 73560 |
|
70 |
67 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
193 |
176 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
141 |
115 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
141 |
115 |
$2K |
| 87276 |
|
267 |
219 |
$2K |
| 87275 |
|
267 |
219 |
$2K |
| G0297 |
Low dose ct scan (ldct) for lung cancer screening |
12 |
12 |
$2K |
| 64494 |
|
15 |
12 |
$1K |
| 73502 |
|
44 |
36 |
$1K |
| 80061 |
Lipid panel |
129 |
123 |
$1K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
59 |
54 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
73 |
72 |
$996.35 |
| 83605 |
|
128 |
86 |
$684.67 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
105 |
98 |
$657.18 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
45 |
36 |
$576.10 |
| 86140 |
|
95 |
89 |
$378.07 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
40 |
25 |
$353.52 |
| 84439 |
|
45 |
41 |
$342.76 |
| 83735 |
|
85 |
79 |
$323.22 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
16 |
14 |
$294.84 |
| 82607 |
|
29 |
27 |
$294.63 |
| 84702 |
|
22 |
12 |
$216.76 |
| 85379 |
|
27 |
24 |
$192.96 |
| 85014 |
|
223 |
194 |
$108.21 |
| 88142 |
|
25 |
24 |
$84.96 |
| 80047 |
|
44 |
39 |
$69.04 |
| 85652 |
|
29 |
27 |
$62.69 |
| 87660 |
|
12 |
12 |
$48.04 |
| 87480 |
|
12 |
12 |
$48.04 |
| 87510 |
|
12 |
12 |
$48.04 |
| 83615 |
|
13 |
12 |
$33.58 |
| 82948 |
|
18 |
12 |
$29.78 |
| 85018 |
|
12 |
12 |
$26.07 |
| 82330 |
|
25 |
25 |
$18.66 |
| 82565 |
|
25 |
25 |
$12.28 |
| 84295 |
|
25 |
25 |
$11.53 |
| 84132 |
|
25 |
25 |
$11.02 |
| 82947 |
|
25 |
25 |
$10.66 |
| 84520 |
|
25 |
25 |
$9.46 |
| 82374 |
|
25 |
25 |
$9.12 |
| 82435 |
|
25 |
25 |
$9.12 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
84 |
59 |
$0.00 |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
13 |
13 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
236 |
166 |
$0.00 |
| C1755 |
Catheter, intraspinal |
277 |
199 |
$0.00 |
| 80329 |
|
26 |
13 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
25 |
20 |
$0.00 |